Satellos Bioscience Inc (MSCLF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,570 | -11,749 | -6,141 | -20,507 | -16,178 |
| Depreciation Amortization | 4 | 1 | 1 | 2,905 | 2,911 |
| Other Working Capital | -743 | -1,546 | -1,865 | -748 | -28 |
| Other Operating Activity | 1,974 | 1,085 | 639 | 123 | 258 |
| Operating Cash Flow | $-16,335 | $-12,209 | $-7,366 | $-18,227 | $-13,037 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -6,854 | 8,475 | N/A | 4,630 | 13,598 |
| PPE Investments | -6 | -3 | N/A | -4 | -4 |
| Investing Cash Flow | $-6,860 | $8,472 | $N/A | $4,626 | $13,594 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,094 | 1,394 | 2 | 31,237 | 182 |
| Other Financing Activity | 0 | 0 | 0 | 7,797 | 0 |
| Financing Cash Flow | $2,094 | $1,394 | $2 | $39,033 | $182 |
| Exchange Rate Effect | 332 | 487 | 3 | 543 | -57 |
| Beginning Cash Position | 40,073 | 40,073 | 40,073 | 16,105 | 16,681 |
| End Cash Position | 19,304 | 38,217 | 32,712 | 42,080 | 17,363 |
| Net Cash Flow | $-20,769 | $-1,856 | $-7,361 | $25,975 | $682 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,335 | -12,209 | -7,366 | -18,227 | -13,037 |
| Capital Expenditure | -6 | -3 | N/A | -4 | -4 |
| Free Cash Flow | -16,341 | -12,212 | -7,366 | -18,231 | -13,041 |